|
GCPS
MCID: GRG001
|
Greig Cephalopolysyndactyly Syndrome malady |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 17Genetics Home Reference, 15GeneReviews, 33OMIM, 22MalaCards See all sources Export this MalaCard |
Genetics Home Reference: Greig cephalopolysyndactyly syndrome is a disorder that affects development of the limbs, head, and face. The features of this syndrome are highly variable, ranging from very mild to severe. People with this condition typically have one or more extra fingers or toes (polydactyly) or an abnormally wide thumb or big toe (hallux). The skin between the fingers and toes may be fused (cutaneous syndactyly). This disorder is also characterized by widely spaced eyes (ocular hypertelorism), an abnormally large head size (macrocephaly), and a high, prominent forehead. Rarely, affected individuals may have more serious medical problems including seizures, developmental delay, and intellectual disability.17
MalaCards: Greig Cephalopolysyndactyly Syndrome, also known as cephalopolysyndactyly syndrome, is related to postaxial polydactyly type a and hypothalamic hamartomas, somatic. An important gene associated with Greig Cephalopolysyndactyly Syndrome is GLI3 (GLI family zinc finger 3), and among its related pathways are Basal cell carcinoma and CRHR Pathway. Affiliated tissues include limb, head and face. Disease Ontology: An acrocephalosyndactylia that has material basis in mutation in the gli3 gene which results in abnormal development located in limb, located in head, located in face.6 NIH Rare Diseases: Greig cephalopolysyndactyly syndrome is a disorder that affects development of the limbs, head, and face. The features of this syndrome are highly variable, ranging from very mild to severe. Greig cephalopolysyndactyly syndrome is caused by mutations in the GLI3 gene. This condition is inherited in an autosomal dominant pattern.30 Wikipedia: Greig cephalopolysyndactyly syndrome is a disorder that affects development of the limbs, head, and...44 more... OMIM: 175700 GeneReviews summary for gcps |
|
Sources: 6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 33OMIM, 32Novoseek , 43UMLS, 40SNOMED-CT See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 175700
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for greig cephalopolysyndactyly syndrome Drug clinical trials:Search ClinicalTrials for greig cephalopolysyndactyly syndrome Search NIH Clinical Center for greig cephalopolysyndactyly syndrome Search CenterWatch for greig cephalopolysyndactyly syndrome |
|
Sources: 16GeneTests See all sources |
|
Sources: 11FMA, 22MalaCards See all sources |
MalaCards organs/tissues related to greig cephalopolysyndactyly syndrome:22Skin FMA organs/tissues related to greig cephalopolysyndactyly syndrome:11Limb, Head, Face
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to greig cephalopolysyndactyly syndrome:(show all 12)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 20KEGG, 36QIAGEN, 10EMD Millipore, 41Thomson Reuters See all sources |
Pathways related to greig cephalopolysyndactyly syndrome according to GeneDecks:
|
|
|
|
Sources: 12Gene Ontology See all sources |
Biological processes related to greig cephalopolysyndactyly syndrome according to GeneDecks:(show all 10)
|
